Isracann announces plan to raise capital

Click Here To View the Entire Article


Cannabis has young Israeli voters flocking to this right-winger

Call it a grass-roots movement.

Powered by his push to legalize cannabis, a politician edged out of Prime Minister Benjamin Netanyahu’s Likud party because his views were too extreme may become the kingmaker in Israel’s next government.

Moshe Feiglin’s new Zehut party is riding support from younger voters to surge in polls, which now show it entering parliament after Israel’s April 9 elections. It’s not a single-issue party, but some supporters are secular leftists or regular stoners looking past Feiglin’s religious and nationalist zeal.


Analysis: How cannabis legalization became 'high priority' in Israel's 2019 vote

With Feiglin blazing trail for legalization, his other more radical policies obscured by cloud of smoke.

If the proverbial alien lands from outer space, it will certainly be impressed by the nature of a country deciding its election on the legalization of cannabis. But that is exactly what is happening now in Israel's 2019 election campaigns.


Israeli approves compassionate use of MDMA to treat PTSD patients

The popular party drug, MDMA, also known as ecstasy, has officially been approved in Israel as a treatment for Post-traumatic stress disorder.

An Israeli government representative learned about the benefits of using MDMA to treat PTSD from the Multidisciplinary Association for Psychedelic Studies (MAPS), a California-based organization. Following their research, Israel has approved using MDMA to treat 50 patients suffering from PTSD.

“The ministry is taking this seriously and with appropriate caution, an in-depth investigation has been carried out,” Ministry of Health official Bella Ben-Gershon told sources. “There is a considerable population in Israel of people suffering from PTSD that is resistant to other treatment.”


Israeli study shows cannabis may relieve autism symptoms

The scientific community has struggled to gain a solid understanding of children suffering from autism. Since this condition affects every child differently, no blanket treatment option has yet been developed to give doctors are starting point when dealing with these type of patients. There is anecdotal evidence suggesting that cannabis might be part of the solution—similar to how it is for epilepsy—yet American researchers have been hindered from digging deeper into the possible benefits.​

But all is not lost. Scientists in Israel appear to have uncovered definitive proof that medical marijuana can help autistic kids deal with the worst of their symptoms and live a better quality of life.


Yes, medical cannabis works. So why deny the anecdotal evidence?

One of the most common arguments against the efficacy of medical cannabis today is that public policy is outpacing real science. Currently, 33 states along with the District of Columbia, Guam and Puerto Rico have passed laws for comprehensive medical cannabis programs -- but critics often point out we’re lacking definitive proof that marijuana safely and effectively treats many of the qualifying conditions.


Israel becomes third country to allow exports of medical marijuana

Israel has given final approval to a law permitting the export of medical marijuana, a move the government expects will catapult investment in local industry and agriculture.

The Cabinet’s decision Sunday came a month after the Israeli parliament unanimously approved the decision, making Israel the third country in the world, after the Netherlands and Canada, to allow export of medical cannabis products.

Israel is home to dozens of companies active in the medical marijuana industry, and approved companies will be able to export to countries where it is legal.


Israel's grass to grow greener, cabinet about to approve cannabis exports

High times are awaiting Israel’s cannabis and tech sectors, as the cabinet is set to approve legislation allowing the export of medical cannabis.

The bill passed its third reading in the Knesset last month and is pending only the cabinet’s and Prime Minister Benjamin Netanyahu’s confirmation to be signed into law, which is expected to happen on Sunday.

Israel is already considered a world leader in cannabis production, and the legalization of exports will boost the sector even more, allowing Israel to compete in an industry that is expected to reach $33 billion worldwide in the next five years. Tax revenue could rise as much as NIS 1b. through the export permit.


New Israeli-US investment fund for cannabis technology

A $30 million cannabis technology venture capital fund is under establishment by Jerusalem-based global investment platform OurCrowd and the 7thirty Opportunity Fund of Boulder, Colorad

The new fund will invest in emerging companies involved in med-tech, ag-tech, retail, e-commerce, marketplaces, SaaS solutions, and deep-tech research related to cannabis. It will be headquartered in Boulder with activities in Israel, Canada and the United States.


Distribution agreement struck between The Greater Cannabis Company and iCAN: Israel Cannabis Ltd.

The Greater Cannabis Company, Inc. (GCAN) has entered into a letter of intent (LOI) with iCAN Cannabis to expand distribution of GCAN’s eluting patch platform into key global markets.

The LOI calls for including commercial-ready formulations to meet medical and recreational market demands, notes a statement from iCAN: Israel Cannabis, an Israeli developer of cannabis-based formulations, clinical trials and cannabis testing.

“Distribution and marketing rights for iCAN will include Israel, Australia, South Africa, Netherlands, South Africa, Mexico, Colombia, Panama, Germany, Austria, Switzerland, Malta, Macedonia and Portuguese territories,” the statement adds.


Subscribe to RSS - Israel